Best Supportive Care of the Patient with Oesophageal Cancer
- PMID: 36551753
- PMCID: PMC9776873
- DOI: 10.3390/cancers14246268
Best Supportive Care of the Patient with Oesophageal Cancer
Abstract
Background: Oesophageal cancer patients have poor survival, and most are unfit for curative or systemic palliative treatment. This article aims to review the best supportive care for oesophageal cancer, focusing on the management of its most frequent or distinctive symptoms and complications.
Methods: Evidence-based review on palliative supportive care of oesophageal cancer, based on Pubmed search for relevant clinical practice guidelines, reviews and original articles, with additional records collected from related articles suggestions, references and societies recommendations.
Results: We identified 1075 records, from which we screened 138 records that were related to oesophageal cancer supportive care, complemented with 48 additional records, finally including 60 records. This review summarizes the management of oesophageal cancer-related main problems, including dysphagia, malnutrition, pain, nausea and vomiting, fistula and bleeding. In recent years, several treatments have been developed, while optimal management is not yet standardized.
Conclusion: This review contributes toward improving supportive care and decision making for oesophageal cancer patients, presenting updated summary recommendations for each of their main symptoms. A robust body of evidence is still lacking, and the best supportive care decisions should be individualized and shared.
Keywords: dysphagia; malnutrition; oesophageal cancer; oesophageal fistula; palliative supportive care.
Conflict of interest statement
The authors declare no conflict of interests.
Figures


Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Self-expanding metal stents in palliative malignant oesophageal dysplasia.Ann Palliat Med. 2014 Apr;3(2):92-103. doi: 10.3978/j.issn.2224-5820.2014.04.03. Ann Palliat Med. 2014. PMID: 25841507
-
Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.JBI Database System Rev Implement Rep. 2015 Jan;13(1):99-111. doi: 10.11124/jbisrir-2015-1809. JBI Database System Rev Implement Rep. 2015. PMID: 26447011
-
An update in the palliative management of malignant dysphagia.Eur J Surg Oncol. 2000 Mar;26(2):116-29. doi: 10.1053/ejso.1999.0754. Eur J Surg Oncol. 2000. PMID: 10744928 Review.
-
Palliative Chemotherapy: Does It Only Provide False Hope? The Role of Palliative Care in a Young Patient With Newly Diagnosed Metastatic Adenocarcinoma.J Adv Pract Oncol. 2017 May-Jun;8(4):382-386. Epub 2017 May 1. J Adv Pract Oncol. 2017. PMID: 30018843 Free PMC article. Review.
Cited by
-
Identification and Characterization of Prognostic Macrophage Subpopulations for Human Esophageal Carcinoma.Curr Med Chem. 2025;32(1):123-135. doi: 10.2174/0109298673284207240108105724. Curr Med Chem. 2025. PMID: 38362682
-
Nanoparticles for cancer therapy: a review of influencing factors and evaluation methods for biosafety.Clin Transl Oncol. 2023 Jul;25(7):2043-2055. doi: 10.1007/s12094-023-03117-5. Epub 2023 Feb 19. Clin Transl Oncol. 2023. PMID: 36807057 Review.
-
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models.Sci Rep. 2024 Mar 18;14(1):6491. doi: 10.1038/s41598-024-57028-8. Sci Rep. 2024. PMID: 38499619 Free PMC article.
References
-
- World Health Organization (WHO) International Agency for Research on Cancer (IARC) Global Cancer Observatory (GLOBOCAN): Cancer Today. 2020. [(accessed on 25 August 2022)]. Available online: http://gco.iarc.fr/today.
-
- Kamangar F., Nasrollahzadeh D., Safiri S., Sepanlou S.G., Fitzmaurice C., Ikuta K.S., Bisignano C., Islami F., Roshandel G., Lim S.S., et al. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 2020;5:582–597. doi: 10.1016/S2468-1253(20)30007-8. - DOI - PMC - PubMed
-
- Ana da Costa Miranda A.M.-d.-S., Glória L., Brito C. Registo Oncológico Nacional de Todos os Tumores na População Residente em Portugal, em 2018. E.P.E.; Lisboa, Portugal: 2021. Reprografia do IPO de Lisboa de Francisco Gentil.
-
- Dandara C., Robertson B., Dzobo K., Moodley L., Parker M.I. Patient and tumour characteristics as prognostic markers for oesophageal cancer: A retrospective analysis of a cohort of patients at Groote Schuur Hospital. Eur. J. Cardio-Thorac. Surg. 2015;49:629–634. doi: 10.1093/ejcts/ezv135. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources